Home » Authors » Brady Huggett

Articles by Brady Huggett

Pain Therapeutics Raises $49.7M In Follow-On; Neose Getting $23M

Sep. 23, 2003

By Brady Huggett

Pain Therapeutics Raises $49.7M In Follow-On; Neose Getting $23M

Sep. 23, 2003

By Brady Huggett

Antigenics Raising $31.6M Via Stock Sale To Single Investor

Sep. 22, 2003

By Aaron Lorenzo and Brady Huggett

Memory Signs Roche To $150M Expansion Of CNS Collaboration

Sep. 19, 2003

By Brady Huggett

Memory Signs Roche To $150M Expansion Of CNS Collaboration

Sep. 19, 2003

By Brady Huggett

ParAllele, Roche Seek Mutations Associated With Type II Diabetes

Sep. 17, 2003

By Brady Huggett

ParAllele BioScience Inc., as part of its move to the commercial side of things, signed a deal with Hoffmann-La Roche Inc. to discover genes and genetic variations around Type II diabetes. (BioWorld Today)

ParAllele, Roche Seek Mutations Associated With Type II Diabetes

Sep. 17, 2003

By Brady Huggett

ParAllele BioScience Inc., as part of its move to the commercial side of things, signed a deal with Hoffmann-La Roche Inc. to discover genes and genetic variations around Type II diabetes. (BioWorld Today)

Armed With Macugen, Eyetech Joins IPO Queue, Seeks $100M

Sep. 16, 2003

By Brady Huggett

Armed With Macugen, Eyetech Joins IPO Queue, Seeks $100M

Sep. 16, 2003

By Brady Huggett

Tercica, Armed With Genentech Technology, Seeks $86.25M IPO

Sep. 15, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.